Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
NextTrip announced that its travel-focused media platform, JOURNY TV, will premiere its first original series, 'I DO: In Destination', on October 4 and 5, 2026. The series is a key part of the company's 'content-to-commerce' strategy, designed to integrate travel inspiration with its booking technology. A third episode is scheduled to be filmed in The Bahamas in October 2026 with support from The Bahamas Ministry of Tourism.
Cheetah Net Supply Chain Service Signs $788K M&A Deal with JoyPak Supply LLC
Cheetah Net Supply Chain Service Inc. entered into a definitive agreement to acquire 100% of the membership interests of JoyPak Supply LLC for $788,000 in cash. JoyPak is a Nevada-based company specializing in the sale of consumer, beauty, and personal care products. The acquisition is intended to diversify Cheetah's product mix and support its long-term growth strategy in new product categories.
Lindblad Expeditions Holdings Signs $61M M&A Deal with White Desert Ltd, PNR Airways Ltd and Echo Charlie Ltd
Lindblad Expeditions acquired a 60% controlling interest in White Desert and Echo Charlie, pioneers in Antarctic interior expeditions and aviation-based experiential travel, for approximately $61 million in cash. The deal includes options for Lindblad to acquire the remaining 40% in 2030 and 2031 and marks the largest transaction in the company's history, significantly expanding its polar exploration portfolio.
Value
$61M
Counterparty
White Desert Ltd, PNR Airways Ltd and Echo Charlie Ltd
BlossomHill Therapeutics announced updated Phase 1/2 SOLARA trial data for BH-30643 in patients with EGFR C797S-positive NSCLC, showing a 45% objective response rate and 88% disease control rate. The results, presented at the 2026 World Conference on Lung Cancer, demonstrate the drug's potential to overcome resistance to existing EGFR inhibitors in a population with no approved targeted therapies. The company plans to advance the candidate into a Phase 2 trial in 2027 following its recent FDA Fast Track designation.
Counterparty
International Association for the Study of Lung Cancer (IASLC)
FibroBiologics entered into a securities purchase agreement with its Chief Scientific Officer, Hamid Khoja, Ph.D., for a private placement of 298,508 shares and equal warrants. The offering is expected to raise approximately $0.5 million in gross proceeds for general corporate purposes and working capital. The securities were priced at $1.675 per unit, representing the previous day's closing bid price plus a warrant premium.
Connect Biopharma announced positive topline results from its global Phase 2 study of rademikibart as an add-on treatment for acute asthma exacerbations. The study met its key secondary endpoint with a statistically significant improvement in lung function (FEV1) at Day 7, and while the primary endpoint of treatment failure reduction (66%) did not reach statistical significance due to lower-than-projected event rates, the company plans to engage with the FDA for a Phase 3 program.
Truist Financial Corporation entered into an agreement to sell $5.5 billion of auto loans, representing substantially all assets of its Regional Acceptance Corporation (RAC) subsidiary. The transaction is part of a strategic exit from the near-prime auto lending business and is expected to generate $5.2 billion in net proceeds and $945 million in CET1 capital.
Vera Therapeutics announced positive topline results from the final efficacy analysis of its Phase 3 ORIGIN 3 trial of TRUTAKNA (atacicept-vymj) in patients with IgA nephropathy. The trial met all prespecified endpoints, demonstrating a 76% reduction in the risk of kidney disease progression and stabilization of kidney function (eGFR) through 104 weeks. The company plans to submit a supplemental BLA for full FDA approval in the fourth quarter of 2026.
Rocket Lab Signs $1.94B M&A Deal with Iridium Communications Inc.
Rocket Lab provided a status and financing update on its pending acquisition of Iridium Communications, announcing the deal is now fully funded. The company completed a $1.944 billion ATM equity offering and amended Iridium's existing $1.775 billion credit facility to permit the change of control, allowing Rocket Lab to terminate a previous $3.6 billion bridge facility.
Transocean Wins $80M Contract from undisclosed operator
Transocean's ultra-deepwater drillship, Deepwater Conqueror, was awarded a two-well contract for work in Equatorial Guinea. The 170-day campaign is expected to begin in 2027 and will contribute approximately $80 million in backlog, excluding mobilization and demobilization fees.
Hubilu Venture Signs $600K M&A Deal with Finance of America Reverse LLC
Hubilu Venture Corporation, through its subsidiary Elata Investments, LLC, completed the acquisition of a real property asset located at 5717 4th Ave in Los Angeles for $600,000. The acquisition was financed in part by a $550,000 first position note from Orchard Funding bearing interest at 9.99% per annum.
Iridium Communications M&A Deal with Rocket Lab Corporation
Iridium Communications entered into a fourth amendment to its credit agreement to facilitate its pending merger with Rocket Lab Corporation. The amendment ensures the transaction does not trigger a 'Change of Control' default and secures lender consent for the merger, while adjusting interest rates and adding a downstream guarantee from Rocket Lab USA, Inc. upon closing.
Atkore Inc. announced the expiration of the HSR Act waiting period regarding its pending acquisition by Prysmian S.p.A. The expiration of the antitrust waiting period satisfies a key closing condition for the merger, which remains subject to stockholder approval and other customary conditions.
Profusa, Inc. received a letter from Nasdaq confirming it has regained compliance with the minimum bid price and stockholders' equity requirements. As a result, the company will be subject to a one-year Mandatory Panel Monitor period, during which any further non-compliance with the equity rule will result in a prompt delisting determination without a cure period. The company intends to continue monitoring its status to maintain its listing on The Nasdaq Capital Market.
InnSuites Hospitality Trust received notice that NYSE American has accepted its compliance plan, granting an extension through December 24, 2027, to regain compliance with continued listing standards. The Trust recently increased stockholders' equity by $3 million and is exploring strategic alternatives, including a potential reverse merger, to meet the exchange's requirements.
Tyra Biosciences entered into an underwriting agreement to raise approximately $400 million through the sale of 9,079,000 shares of common stock and 9,078,529 pre-funded warrants. The offering was led by RA Capital Management and includes participation from several institutional investors to fund the development of dabogratinib and other pipeline programs. The common stock is priced at $22.03 per share, with the offering expected to close on September 15, 2026.
House of Doge Inc. (formerly Brag House Holdings, Inc.) completed its merger with House of Doge Inc. (Texas), which now survives as a wholly-owned subsidiary. The transaction was structured as a reverse recapitalization where the Texas-based House of Doge is the accounting acquirer, and the company has rebranded and changed its ticker to 'HODO' on the Nasdaq.
DevvStream M&A Deal with XCF Global, Inc. and Southern Energy Renewables Inc.
DevvStream Corp. entered into an amendment to its existing business combination agreement with XCF Global and Southern Energy Renewables. The amendment modifies the pro forma ownership structure, increasing DevvStream shareholders' post-merger stake to approximately 10.43% while reducing Southern Energy's stake to approximately 20%.
Counterparty
XCF Global, Inc. and Southern Energy Renewables Inc.
Nextera Energy M&A Deal with Dominion Energy, Inc.
NextEra Energy and Dominion Energy announced an enhanced Virginia benefits package to support their pending merger, including four years of residential bill credits and $100 million in low-income assistance. The update also commits to creating 1,000 new jobs in Virginia and building a new shareholder-funded co-headquarters tower in Richmond to address stakeholder feedback and regulatory priorities.
Z Squared Signs $5M M&A Deal with Paradox Data, LLC
Z Squared Inc. completed the acquisition of 100% of Paradox Data, LLC from Paradox Infrastructure LLC for $5 million in Series A Convertible Preferred Stock. The acquisition includes the Union County Campus in Arkansas, an energized data center site with 8.0 MW of existing power capacity and a development target of 150+ MW for AI infrastructure.
Value
$5M
Counterparty
Paradox Data, LLC
“In August we told our shareholders to judge us on four things: whether the Paradox acquisition closes, whether we sign our first paying tenant and megawatt commitments, whether energized capacity at Union County grows beyond the current 8 megawatts, and whether we add sites without taking on debt. We have met our first goal. We closed, we paid in stock, and we took on no debt to do it.”
David Halabu, Chief Executive Officer of Z Squared
BIO-TECHNE M&A Deal with Merck KGaA, Darmstadt, Germany
Bio-Techne Corporation provided a status update on its pending merger with Merck KGaA, Darmstadt, Germany, specifically addressing shareholder litigation and demand letters alleging disclosure deficiencies in the proxy statement. To avoid potential delays to the merger and the scheduled September 23, 2026 shareholder vote, the company has voluntarily issued supplemental disclosures while maintaining that the legal claims are without merit.
Payoneer Global Inc. stockholders approved the company's acquisition by Nuvei (Neon Maple Parent Inc.) at a special meeting held on September 14, 2026. Under the terms of the merger agreement, Payoneer will become a wholly owned subsidiary of Nuvei. Stockholders also approved the merger-related executive compensation on a non-binding, advisory basis.
The Elmet Group received a $450 million committed investment from the U.S. Department of War's Economic Defense Unit to accelerate domestic tungsten manufacturing and secure critical mineral supply chains. The funding will support over $165 million in facility expansions across Maine, Michigan, and Ohio, as well as global mining operations in Australia and Spain. Additionally, the company secured a separate agreement worth up to $2 billion to support the National Defense Stockpile.
Value
$450M
Counterparty
United States Department of War
Earnings call
Aug 30, 2033, 9:00 AM ET
“This investment represents an important step toward securing a resilient supply of tungsten, a material that is critical to America’s defense, industrial, and economic future. The Elmet Group’s vertically integrated production capabilities, sourcing strategy, and commitment to expanding capacity positions our company to play a meaningful role in strengthening supply chains.”
Dominion Energy M&A Deal with NextEra Energy, Inc.
Dominion Energy and NextEra Energy announced an enhanced Virginia benefits package related to their proposed merger, including doubling residential bill credits to four years and expanding low-income assistance by $100 million. The package also commits to creating 1,000 new jobs, building a new co-headquarters tower in Richmond, and establishing a $1 billion annual Virginia Supplier Program to support the local supply chain.
Drugs Made In America Acquisition Corp., a Special Purpose Acquisition Company (SPAC), has entered into a material definitive agreement, which typically signifies a definitive merger agreement or business combination with a target company. As a SPAC, this filing represents a major strategic milestone toward completing its initial business combination.
Sysco Corporation filed audited and pro forma financial statements related to its previously announced merger agreement with Jetro Restaurant Depot (JRD Unico Inc. and Warehouse Realty, LLC). The filing serves as a status and regulatory update to facilitate the incorporation of the target company's financial data into Sysco's registration statements as the acquisition progresses.
XCF Global M&A Deal with DevvStream Corp. and Southern Energy Renewables Inc.
XCF Global entered into an amendment to its existing business combination agreement with DevvStream Corp. and Southern Energy Renewables. The amendment adjusts the pro forma ownership percentages, resulting in Southern Energy shareholders holding 20% and DevvStream shareholders holding 10.43% of the combined company upon closing.
Counterparty
DevvStream Corp. and Southern Energy Renewables Inc.
Enova International M&A Deal with Grasshopper Bancorp, Inc.
Enova International has withdrawn its regulatory applications with the OCC and Federal Reserve for the proposed acquisition of Grasshopper Bancorp, Inc. The company cited a lack of clear regulatory standards for nonbanks and stated its future growth does not depend on becoming a bank. Enova reaffirmed its 2026 financial guidance and announced plans to accelerate share repurchases for the remainder of the year.
Longeveron Inc. has regained compliance with Nasdaq's $1.00 minimum bid price requirement after its Class A common stock maintained a closing price of at least $1.00 for 10 consecutive business days. The company had previously been under a deficiency notice since September 2025 and was granted two 180-day extension periods to resolve the issue. Nasdaq has officially closed the matter, securing the company's continued listing on The Nasdaq Capital Market.
PDS Biotechnology completed the initial closing of a PIPE financing led by Nant Capital, raising $11.3 million in gross proceeds through the sale of common stock and warrants. The company also announced a contingent milestone closing for an additional $11 million and appointed Dr. Patrick Soon-Shiong and James Banaag to its Board of Directors. Proceeds will be used to repay $4.6 million in debt to Yorkville and advance the PDS0301 clinical program.